IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
683.72
-4.76 (-0.69%)
Dec 29, 2025, 1:39 PM EST - Market open
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 10 analysts that cover IDEXX Laboratories stock have a consensus rating of "Buy" and an average price target of $700.5, which forecasts a 2.45% increase in the stock price over the next year. The lowest target is $475 and the highest is $850.
Price Target: $700.5 (+2.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $850 | Buy | Initiates | $850 | +24.32% | Dec 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $765 → $805 | Buy | Maintains | $765 → $805 | +17.74% | Nov 4, 2025 |
| UBS | UBS | Hold Maintains $710 → $750 | Hold | Maintains | $710 → $750 | +9.69% | Nov 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $675 → $775 | Buy | Maintains | $675 → $775 | +13.35% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Maintains $785 → $830 | Strong Buy | Maintains | $785 → $830 | +21.39% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
4.37B
from 3.90B
Increased by 12.15%
Revenue Next Year
4.75B
from 4.37B
Increased by 8.72%
EPS This Year
13.15
from 10.67
Increased by 23.24%
EPS Next Year
14.79
from 13.15
Increased by 12.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.5B | 5.0B | ||||
| Avg | 4.4B | 4.8B | ||||
| Low | 4.2B | 4.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.7% | 13.3% | ||||
| Avg | 12.1% | 8.7% | ||||
| Low | 7.6% | 3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.64 | 16.26 | ||||
| Avg | 13.15 | 14.79 | ||||
| Low | 12.21 | 13.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 27.8% | 23.6% | ||||
| Avg | 23.2% | 12.5% | ||||
| Low | 14.4% | 5.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.